Parents Unaware of ‘Study Drug’ Used by Teens

Drug News

ANN ARBOR – As high schoolers prepare for final exams, teens nationwide may be tempted to use a “study drug” ­– a prescription stimulant or amphetamine – to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that their teen has used a study drug.

Study drugs refer to stimulant medications typically prescribed for the treatment of attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in this category include Adderall, Concerta, Ritalin, and Vyvanse.

Among parents of teens who have not been prescribed a stimulant medication for ADHD, just 1% said they believe their teen has used a study drug to help study or improve grades, according to the latest University of Michigan Mott Children’s Hospital National Poll on Children’s Health. However, recent national data from Monitoring the Future indicate that 10% of high school sophomores and 12% of high school seniors say they’ve used an amphetamine or stimulant medication not prescribed by their doctor.

Sometimes students without ADHD take someone else’s medication, to try to stay awake and alert and try to improve their scores on exams or assignments. Taking study drugs has not been proven to improve students’ grades, and it can be very dangerous to their health, says Dr. Matthew M. Davis, director of the C.S. Mott Children’s Hospital National Poll on Children’s Health.

“Taking these medications when they are not prescribed for you can lead to acute exhaustion, abnormal heart rhythms and even confusion and psychosis if the teens get addicted and go into withdrawal,” says Davis.

“What we found in this poll is a clear mismatch between what parents believe and what their kids are reporting. But even though parents may not be recognizing these behaviors in their own kids, this poll also showed that one-half of the parents say they are very concerned about this abuse in their communities,” Davis says.


https://www.heritage.com/articles/2013/05/29/ann_arbor_journal/news/doc51a6452267266439298305.txt

Menu